Hudson Bay Capital Management LP

170 employees

Hudson Bay Capital Management is a private company categorized under Management Services and located in New York, NY.

Investor insights

Sectors invested in

Biotechnology6

Health Care5

Pharmaceutical4

Medical2

Therapeutics2

Life Science2

R&D1

Health Diagnostics1

Medical Device1

Manufacturing1

Biopharma1

conditionally active biologics1

antibody evolution and engineering1

protein evolution and engineering1

development of novel cancer immunotherapies1

autoimmune1

cell therapy1

lupus1

Immunology1

B-Cell Cloning1

Funding rounds participated in

$85M sweet spot round size

Most of their 8 investments are in rounds between $62M and $98M

Basic info

Industry

financial services

Sectors

Impact Investing

Date founded

2005

Investments made

Kyverna Therapeutics raised $85M on January 26, 2022

Investors: LYFE Capital, Westlake Village BioPartners®, Intellia Therapeutics, Inc., Insight Partners, Vida Ventures, LLC, RTW Investments, LP, Northpond Ventures and Hudson Bay Capital Management LP

BioAtla, Inc. raised $75M on September 29, 2021

Investors: Ikarian Capital LLC, Great Point Partners, Monashee Investment Management LLC, Soleus Capital Management, L.P., Pappas Capital and Hudson Bay Capital Management LP

Scivita Medical Technology Co.,Ltd raised $62M on August 5, 2021

Investors: 经纬创投（北京）投资管理顾问有限公司, Lilly Asia Ventures and Hudson Bay Capital Management LP

CANbridge Life Sciences Ltd. raised $43M on December 1, 2020

Investors: LYFE Capital, Summer Capital, Casdin Capital, LLC, RA Capital Management, L.P., Bulldog Innovation Group and Hudson Bay Capital Management LP

HARBOUR BIOMED raised $103M on July 9, 2020

Investors: Octagon Capital, 碧桂园集团, OrbiMed Advisors and Hudson Bay Capital Management LP

Legend Biotech raised $151M on April 1, 2020

Investors: Lilly Asia Ventures, RA Capital Management, L.P., Vivo Capital and Hudson Bay Capital Management LP

Rongchang Pharmaceutical Co., Ltd. raised undisclosed on March 16, 2020

Investors: Lake Bleu Capital (Hong Kong) Limited, Lilly Asia Ventures, OrbiMed Advisors, Janchor Industrialist Investing | 建峖實業投資, Vivo Capital and Hudson Bay Capital Management LP

CANbridge Life Sciences Ltd. raised $98M on February 18, 2020

Investors: Yuanming Capital, General Atlantic, WuXi AppTec, Tigermed, RA Capital Management, L.P. and Hudson Bay Capital Management LP